EBV status has prognostic implication among young patients with angioimmunoblastic T‐cell lymphoma

EBV status has prognostic implication among young patients with angioimmunoblastic T‐cell lymphoma

Abstract Epstein‐Barr virus (EBV)‐positive B cells have been detected in 66%‐86% of patients with angioimmunoblastic T‐cell lymphoma (AITL). However, it remains controversial whether EBV status has an impact on the survival of patients with AITL. In this study, we aimed to reevaluate the impact of E...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmed E. Eladl, Kazuyuki Shimada, Yuka Suzuki, Taishi Takahara, Seiichi Kato, Kei Kohno, Ahmed Ali Elsayed, Chun‐Chieh Wu, Takashi Tokunaga, Tomohiro Kinoshita, Mamiko Sakata‐Yanagimoto, Shigeo Nakamura, Akira Satou
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Cancer Medicine
Subjects:	angioimmunoblastic T‐cell lymphoma Epstein‐Barr virus prognostic indicator survival curve young
Online Access:	https://doi.org/10.1002/cam4.2742
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infections
by: Xiaodan Zheng, et al.
Published: (2025-01-01)

Immunological Prevalence of EBV in Rheumatoid Arthritis Iraqi Patients
by: Wafaa Ayad Al-Nuaimy, et al.
Published: (2025-07-01)

A case of angioimmunoblastic T-cell lymphoma mimicking angioedema
by: He Zhao, et al.
Published: (2025-06-01)

Active EBV infection in children: associations between DNA load, infection status, immune status, and disease severity
by: Haipeng Yan, et al.
Published: (2025-04-01)

The role of EBV lytic genes in tumor development and progression
by: DENG Yizhang, et al.
Published: (2024-09-01)

REACTIVE PLASMACYTOSIS AT THE ONSET OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA. CASE REPORT
by: N. G. Chernova, et al.
Published: (2018-02-01)

Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies
by: Yurou Xing, et al.
Published: (2025-03-01)

[Translated article] An Update on EBV-related Cutaneous Lymphoproliferative Disorders: a Systematic Review
by: S. García-González, et al.
Published: (2025-04-01)

EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma
by: Weiwei Zhang, et al.
Published: (2025-04-01)

In silico Approach of Some Selected Manuka Honey Constituents as Epstein–Barr Virus (EBV) Nuclear Antigen 1 (EBNA1) Inhibitors
by: Achmad Chusnu Romdhoni, et al.
Published: (2023-12-01)

Histopathological characteristics of Epstein-Barr virus (EBV)–associated encephalitis and colitis in chronic active EBV infection
by: Betty A Kasimo, et al.
Published: (2025-05-01)

Acute hepatitis: a rare complication of Epstein-Barr virus (EBV) infection
by: Mehmet Uluğ, et al.
Published: (2010-10-01)

Low prognostic nutritional index predicts poor outcome in newly diagnosed angioimmunoblastic T-cell lymphoma
by: Renqin Li, et al.
Published: (2025-06-01)

Delayed diagnosis of angioimmunoblast T-cell lymphoma presenting with immunoglobulin a vasculitis
by: Lu Xu, et al.
Published: (2024-12-01)

PET/CT-Based prognostic model enhances early survival prediction in angioimmunoblastic t-cell lymphoma
by: Xiaoxia Xu, et al.
Published: (2025-07-01)

Synchronous primary parotid tuberculosis and EBV-associated primary lymphoepithelial carcinoma
by: Anandhi Anbalagan, et al.
Published: (2025-04-01)

Оptimization of Treatment EBV Infectious Mononucleosis in Children
by: V. B. Kotlova, et al.
Published: (2015-10-01)

Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas
by: Ying Li, et al.
Published: (2025-08-01)

Epstein–Barr virus and mechanisms of molecular carcinogenesis
by: A. D. Molchanov, et al.
Published: (2025-06-01)

Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges
by: Febri Gunawan Sugiokto, et al.
Published: (2025-01-01)

Genetic evidence identifies a causal relationship between EBV infection and multiple myeloma risk
by: Jian Li, et al.
Published: (2025-02-01)

Epstein-Barr virus (EBV) DNAemia in saliva of viral encephalitis and nasopharyngeal carcinoma patients
by: Nanditha Srinivasan, et al.
Published: (2025-01-01)

Exploring the interplay between EBV and autophagy-related gene expression patterns in nasopharyngeal carcinoma
by: Abdullah E. Alanazi, et al.
Published: (2025-06-01)

A Liposome-Based Nanoparticle Vaccine Induces Effective Immunity Against EBV Infection
by: Ping Li, et al.
Published: (2025-03-01)

IN VITRO EFFECTS OF MEVASTATIN AND BIOLOGICAL PREPARATIONS UPON ACTIVATION OF EBV-SPECIFIC CD4+T LYMPHOCYTES FROM THE PATIENTS WITH RHEUMATOID ARTHRITIS
by: I. V. Shirinsky, et al.
Published: (2014-07-01)

ebv-sisRNA-3 contributes to the formation of G4-associated R-loop upstream of EBV lytic replication origin in latently infected cells
by: Bo Wang, et al.
Published: (2025-06-01)

A nomogram integrating clinical stage and pre-EBV DNA to identify the cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Sunqin Cai, et al.
Published: (2025-06-01)

Constructing a predictive model based on peripheral blood signs to differentiate infectious mononucleosis from chronic active EBV infection
by: Jin hua Yuan, et al.
Published: (2024-09-01)

High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi
by: Nathan D. Montgomery, et al.
Published: (2020-01-01)

Exploring the role of EBV ZEBRA antibody levels in papillary thyroid cancer risk and drug resistance
by: Jiaqin Deng, et al.
Published: (2025-04-01)

Successful treatment of an elderly patient with relapsed/refractory angioimmunoblastic T-cell lymphoma with the PI3Kδ inhibitor linperlisib: a Case Report
by: Ming-Qiang Chu, et al.
Published: (2025-05-01)

Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens
by: Xue-Qi Li, et al.
Published: (2025-07-01)

Causal association between EBV and gastritis, gastric cancer, and gastric ulcer: a two-sample Mendelian randomization study
by: Xiaoyuan Qiao, et al.
Published: (2025-07-01)

Anti-EBV: Artificial intelligence driven predictive modeling for repurposing drugs as potential antivirals against Epstein-Barr virus
by: Hiteshi Vaidya, et al.
Published: (2025-01-01)

Recent Progress in the Vaccine Development Against Epstein–Barr Virus
by: Yihao Dai, et al.
Published: (2025-06-01)

Epstein-Barr Virus Infection in Children: Improving the Diagnosis and Treatment Program
by: E. N. Simovanyan, et al.
Published: (2016-04-01)

EBV-Positive Lymphoproliferative Diseases: A New Concept and Differential Diagnosis (Literature Review and Case Reports)
by: АM Kovrigina
Published: (2018-10-01)

Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China
by: Qiu-Yuan Xiang, et al.
Published: (2025-06-01)

The value of a PET scan in selecting the best lymph node to biopsy, and confirming the diagnosis of idiopathic multicentric Castleman disease with HLH and EBV viremia in a previously healthy adult
by: Erica Bitektine, et al.
Published: (2024-11-01)

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
by: Qian Wu, et al.
Published: (2023-12-01)